248 related articles for article (PubMed ID: 19752885)
1. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure.
Tribouilloy C; Rusinaru D; Leborgne L; Peltier M; Massy Z; Slama M
Am J Cardiol; 2008 Mar; 101(5):639-44. PubMed ID: 18308013
[TBL] [Abstract][Full Text] [Related]
3. A propensity score-based case-control study of renin-angiotensin system gene polymorphisms and diastolic heart failure.
Wu CK; Luo JL; Wu XM; Tsai CT; Lin JW; Hwang JJ; Lin JL; Tseng CD; Chiang FT
Atherosclerosis; 2009 Aug; 205(2):497-502. PubMed ID: 19185300
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: a 12-year follow-up study.
Lee JK; Wu CK; Tsai CT; Lin LY; Lin JW; Chien KL; Hwang JJ; Lin CL; Tseng CD; Chiang FT
Pharmacogenet Genomics; 2013 Apr; 23(4):181-9. PubMed ID: 23407050
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
[TBL] [Abstract][Full Text] [Related]
6. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
7. Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics.
Bautista LE; Vargas CI; Oróstegui M; Gamarra G
Hypertens Res; 2008 Mar; 31(3):401-8. PubMed ID: 18497458
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system gene polymorphisms and atrial fibrillation: a regression approach for the detection of gene-gene interactions in a large hospitalized population.
Tsai CT; Hwang JJ; Chiang FT; Wang YC; Tseng CD; Tseng YZ; Lin JL
Cardiology; 2008; 111(1):1-7. PubMed ID: 18239384
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
11. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.
Ravn LS; Benn M; Nordestgaard BG; Sethi AA; Agerholm-Larsen B; Jensen GB; Tybjaerg-Hansen A
Pharmacogenet Genomics; 2008 Jun; 18(6):525-33. PubMed ID: 18496132
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
[TBL] [Abstract][Full Text] [Related]
13. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.
Franco E; Palumbo L; Crobu F; Anselmino M; Frea S; Matullo G; Piazza A; Trevi GP; Bergerone S
BMC Med Genet; 2007 May; 8():27. PubMed ID: 17519002
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.
Mukae S; Itoh S; Aoki S; Iwata T; Nishio K; Sato R; Katagiri T
J Hum Hypertens; 2002 Dec; 16(12):857-63. PubMed ID: 12522467
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system gene polymorphisms and atrial fibrillation.
Tsai CT; Lai LP; Lin JL; Chiang FT; Hwang JJ; Ritchie MD; Moore JH; Hsu KL; Tseng CD; Liau CS; Tseng YZ
Circulation; 2004 Apr; 109(13):1640-6. PubMed ID: 15023884
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis.
Gürkan A; Emingil G; Saygan BH; Atilla G; Köse T; Baylas H; Berdeli A
Arch Oral Biol; 2009 Apr; 54(4):337-44. PubMed ID: 19162259
[TBL] [Abstract][Full Text] [Related]
20. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
